by Q1Web Admin | May 10, 2017 | News
Abbot has unveiled its latest medical device, a smartphone-compatible cardiac monitor, Confirm Rx. The device allows physicians to remotely monitor arrhythmia and guide treatment decisions. The smartphone capabilities also enable patients to take a more active...
by Q1Web Admin | May 10, 2017 | News
For the first time in nearly two decades, a drug has been approved to treat amyotrophic lateral sclerosis, which is commonly referred to as Lou Gehrig’s disease. The drug, Radicava, is only the second drug to be approved by the FDA for this particular disease. In a...
by Q1Web Admin | May 3, 2017 | News
Researchers have given mice a boost at the Salk Institute, noting that the mice which received an “exercise in a pill” like drug ran on the treadmill 70% longer than those who did not receive the pill. The pill works by stimulating the PPARD gene. Researchers are...
by Q1Web Admin | May 3, 2017 | News
Pfizer and Merck have reported profit rises in the first quarter of 2017, signaling a positive year for the life science industry. Pfizer out-earned its projected Q1 profits with sales of breast cancer drug Ibrance and pain reliever Lyrica. Ibrance is expected to see...
by Q1Web Admin | May 3, 2017 | News
Outset Medical has raised $76.5 million in a Series C round for its Tablo Hemodialysis System. The all-in-one dialysis device is meant to help patients access lower cost and labor intensive dialysis care. The device eliminates the need for centralized water processing...
